Vasista Vittal 4
4 · REGENXBIO Inc. · Filed Jul 15, 2022
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Vasista Vittal
See Remarks
Transactions
- Sale
Common Stock
2022-07-13$30.01/sh−4,332$129,988→ 158,108 total - Sale
Common Stock
2022-07-14$30.00/sh−468$14,040→ 157,640 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $30.0000 to $30.0065. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.